Healthcare
•3755 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3755)
| Company | Market Cap | Price |
|---|---|---|
|
APM
Aptorum Group Limited
Aptorum plans near-term revenue from biopharma services via the DiamiR merger, aligning with contract research/Development outsourcing.
|
$5.95M |
$1.07
+1.42%
|
|
LYRA
Lyra Therapeutics, Inc.
XTreo drug-delivery platform is Lyra's core product, enabling six months of localized drug therapy via in-office implant (LYR-210).
|
$5.94M |
$3.60
-0.42%
|
|
SSKN
STRATA Skin Sciences, Inc.
STRATA's core offerings are dermatology-focused excimer laser systems and related medical devices (XTRAC, Pharos lasers; VTRAC lamp systems; TheraClear X), which are medical devices and equipment.
|
$5.67M |
$1.33
-2.21%
|
|
PMCB
PharmaCyte Biotech, Inc.
PMCB develops oncology-focused cell-based therapies (Cell-in-a-Box encapsulation) aligned with Biotech - Oncology.
|
$5.64M |
$0.95
+14.10%
|
|
LCTC
Lifeloc Technologies, Inc.
Lifeloc Technologies manufactures breath alcohol testing devices, which are diagnostic instruments used for disease detection and monitoring.
|
$5.56M |
$2.40
|
|
CLDI
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics directly develops cancer therapies (oncolytic virus platforms) targeting oncology indications.
|
$5.54M |
$1.15
-0.86%
|
|
BUDZ
WEED, Inc.
Sangre AgroTech represents plant genomic research services, akin to contract research and development.
|
$5.44M |
$0.04
|
|
PAVM
PAVmed Inc.
EsoGuard and EsoCheck are proprietary diagnostic devices/tests used for esophageal precancer detection, a direct diagnostic equipment product line.
|
$5.40M |
$7.30
-1.08%
|
|
DFCO
Dalrada Financial Corporation
Infusion pharmacy and compounding facility fall under healthcare services & facilities.
|
$5.38M |
$0.03
|
|
APRE
Aprea Therapeutics, Inc.
APRE is an oncology-focused biotech developing cancer therapies, namely DDR inhibitors, which aligns with Biotech - Oncology.
|
$5.24M |
$0.92
+2.22%
|
|
GOVX
GeoVax Labs, Inc.
GeoVax directly develops and manufactures vaccines using its MVA platform for infectious diseases (Mpox/smallpox and COVID-19 programs).
|
$5.16M |
$0.19
-7.66%
|
|
ALBT
Avalon GloboCare Corp.
KetoAir breathalyzer is a directly produced diagnostic equipment device sold as a precision diagnostic product.
|
$5.14M |
$1.06
-20.52%
|
|
CPHI
China Pharma Holdings, Inc.
Core product: generic drugs manufacturing (Helpson's portfolio in PRC).
|
$5.07M |
$1.55
-0.26%
|
|
INBS
Intelligent Bio Solutions Inc.
INBS directly develops and sells the Intelligent Fingerprinting Platform, a diagnostic device for non-invasive drug screening (fingerprint sweat-based testing) and associated cartridges/readers.
|
$4.94M |
$5.97
+8.55%
|
|
CDIO
Cardio Diagnostics Holdings, Inc.
Provides laboratory testing services and advisory support for diagnostics.
|
$4.92M |
$2.35
-15.95%
|
|
IMRN
Immuron Limited
Core polyclonal antibody technology platform powering gut-health products and clinical programs in immunology/biotherapeutics.
|
$4.90M |
$0.82
-4.64%
|
|
KALA
KALA BIO, Inc.
KPI-012 is a mesenchymal stem cell secretome (MSC-S) therapy, aligning with Biotech - Cell Therapy.
|
$4.67M |
$0.63
-5.53%
|
|
ACXP
Acurx Pharmaceuticals, Inc.
Lead product ibezapolstat is an oral small-molecule antibiotic for CDI, aligning with the 'Oral Small Molecule Therapeutics' investable theme.
|
$4.61M |
$2.96
+1.72%
|
|
NAOV
NanoVibronix, Inc.
Core business is medical devices, including legacy wound/pain therapies and new ENvue enteral-feeding technology.
|
$4.37M |
$4.06
-5.80%
|
|
XAIR
Beyond Air, Inc.
LungFit is a medical device platform that generates nitric oxide and is sold/distributed to hospitals.
|
$4.33M |
$0.94
+13.69%
|
|
POAI
Predictive Oncology Inc.
Biotech - Oncology focus via proprietary biobank, wet-lab validation, and AI-enabled oncology drug discovery.
|
$4.32M |
$5.94
-0.17%
|
|
TTNP
Titan Pharmaceuticals, Inc.
Titan's core ProNeura technology is a long-acting drug delivery platform used for subdermal implants.
|
$4.21M |
$4.61
|
|
SONN
Sonnet BioTherapeutics Holdings, Inc.
Sonnet's core pipeline is oncology-focused immunotherapies (e.g., SON-1010 IL-12) leveraging the FHAB platform.
|
$3.99M |
$1.28
+1.98%
|
|
HCWC
Healthy Choice Wellness Corp.
HCWC runs licensed wellness centers offering services such as IV nutrient drips, i.e., Healthcare Services & Facilities.
|
$3.98M |
$0.30
-43.17%
|
|
ADMT
ADM Tronics Unlimited, Inc.
Company designs and manufactures medical devices and biometric sensing technologies including diagnostics and therapeutics.
|
$3.94M |
$0.11
|
|
LQMT
Liquidmetal Technologies, Inc.
Medical Device Components: Liquidmetal designs/manufactures customized components for medical devices using its amorphous alloys.
|
$3.91M |
$0.10
|
|
OGEN
Oragenics, Inc.
ONP-002 uses a proprietary intranasal drug-delivery platform (powder formulation + breath-propelled device).
|
$3.77M |
$0.95
+2.56%
|
|
LADX
LadRx Corporation
LadRx is a biotechnology company focused on oncology drug development.
|
$3.70M |
$0.11
|
|
GTCH
GBT Technologies Inc.
GTCH's qTerm device and biometrics relate to medical devices/biometrics category.
|
$3.70M |
$0.00
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$3.65M |
$3.09
-8.85%
|
|
SILO
Silo Pharma, Inc.
Drug Delivery Platforms directly describes Silo's intranasal and implantable drug delivery technologies (SPC-15, SPC-14, SP-26).
|
$3.59M |
$0.39
+1.86%
|
|
BCLI
Brainstorm Cell Therapeutics Inc.
NurOwn is a proprietary autologous cell therapy platform developed by Brainstorm for ALS and related neurodegenerative indications, directly produced and administered by the company.
|
$3.59M |
$0.61
|
|
NAKA
Kindly MD, Inc.
Provides patient-first healthcare services and operates clinics/delivery of care under KindlyMD.
|
$3.57M |
$0.45
-4.13%
|
|
AIM
AIM ImmunoTech Inc.
Ampligen is AIM ImmunoTech's flagship oncology/immunotherapy platform and is being developed with cancer indications (pancreatic and ovarian cancer) in combination with checkpoint inhibitors.
|
$3.49M |
$1.19
|
|
SOBR
SOBR Safe, Inc.
SOBR directly manufactures biometric-enabled medical devices (SOBRcheck) and wearable monitoring hardware (SOBRsure) paired with a cloud software platform.
|
$3.34M |
$2.19
-0.23%
|
|
ZYXI
Zynex, Inc.
Company emphasizes Patient Monitoring Solutions as a core growth area with NiCO and related devices.
|
$3.11M |
$0.13
+2.22%
|
Showing page 36 of 38 (3755 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
